Search

A study from MSK takes a deeper look at some of the causes of secondary leukemia.

… Monday, September 9, 2019 Summary A new study from Memorial Sloan Kettering suggests that in some people treated for breast cancer, leukemia-causing gene mutations may be present in blood cells from the time the original cancer was diagnosed. This helps explain some cases of secondary leukemia. Doctors

it means to survive cancer and learn how MSK is honoring all cancer survivors this year during National Cancer Survivor Month.

… Wednesday, June 17, 2020 Seth Frankel sitting in a red chair “Being a cancer survivor is a little bit like being a superhero: Not everyone will know your secret identity, but you have an ability to summon a hidden strength that can overcome any obstacle standing in your way.” — Seth Frankel, age 39,

Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College.

… Tuesday, May 11, 2010 Martin S. Tallman, MD, has been appointed Chief of the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. “We are very fortunate to have Dr. Tallman join the Memorial Sloan Kettering

In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy.

… Monday, March 14, 2022 In an ongoing effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving chimeric antigen receptor (CAR) T therapy for some types of leukemia and lymphoma. With CAR T therapy, a patient’s

Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.

… Thursday, July 8, 2021 All creatures need to carefully manage their diet to stay alive. Food may not always be available, so organisms from insects to humans have developed an innate sense of when to burn energy and when to save it for later. Living things stockpile energy in the form of fat cells called

A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.

… Wednesday, November 20, 2024 Researchers at the University of British Columbia (UBC), BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer — cancer-like mutations appearing in the cells of healthy women

Four MSK researchers out of 15 winners nationwide were named recipients of the prestigious award. They will each receive a grant of up to $600,000 per year for seven years to support their research in cancer.

… Thursday, October 29, 2020 Four distinguished researchers at Memorial Sloan Kettering (MSK), Joan Massagué, PhD ; Maria Jasin, PhD ; David A. Scheinberg, MD, PhD ; and Hans-Guido Wendel, MD , were named recipients of the National Cancer Institute’s (NCI) 2020 Outstanding Investigator Award (OIA). As

Researchers have redesigned CAR T cells in hopes of improving immunotherapy treatment for multiple myeloma.

… Thursday, March 28, 2019 Summary CAR T cell therapy for multiple myeloma has targeted a protein called BCMA. However, many people treated with this immunotherapy have had their cancer return. Researchers have developed an additional class of CAR T cells that target a protein called GPRC5D. This might

Tomya Watt, Chief Diversity Officer and Vice President of Talent Acquisition and Mobility, was selected to receive the 2022 Moves Mentor Award from ’Moves‘ Magazine.

… Friday, May 20, 2022 Tomya Watt , Chief Diversity Officer and Vice President of Talent Acquisition and Mobility, was selected to receive the 2022 Moves Mentor Award from Moves  magazine. The award celebrates female leaders, the role they play in shaping the next generation, and the energy, expertise,

… Monday, March 3, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Vinod Balachandran Awarded the Marcus Foundation Medical Research Award Vinod Balachandran, MD Vinod Balachandran, MD  surgeon-scientist and Director of the Olayan Center for Cancer